Physician
Internal Medicine
Dr. Sanjay Asthana, MD
|
|
Give Review
Doctor Sanjay Asthana, MD practices Internal Medicine. He received 1 awards: "Regional Top Doctor". Sanjay Asthana has written publications. He has 63 publications published with PubMed. The lastest publication is: 'Cerebrospinal fluid ratios with A42 predict preclinical brain -amyloid accumulation.' He accepts Medicare.
Publications
- Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition.
- Occupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's Disease.
- Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
- Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOE ε4 Carriers.
- Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer's disease.
- Physical activity attenuates age-related biomarker alterations in preclinical AD.
- Cardiorespiratory fitness is associated with brain structure, cognition, and mood in a middle-aged cohort at risk for Alzheimer's disease.
- Posteromedial hyperactivation during episodic recognition among people with memory decline: findings from the WRAP study.
- Insulin resistance predicts brain amyloid deposition in late middle-aged adults.
- Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease.
- Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease.
- Effects of hormone therapy on cognition and mood.
- Amyloid Burden, Neuronal Function, and Cognitive Decline in Middle-Aged Adults at Risk for Alzheimer's Disease.
- The KEEPS-Cognitive and Affective Study: Baseline Associations between Vascular Risk Factors and Cognition.
- Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.
- Amyloid burden and neural function in people at risk for Alzheimer's Disease.
- Rational and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS Cog).
- Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data.
- Low cerebral blood flow is associated with lower memory function in metabolic syndrome.
- Neurobiological Underpinnings of the Estrogen - Mood Relationship.
- The Effects of Ramipril in Individuals at Risk for Alzheimer's Disease: Results of a Pilot Clinical Trial.
- CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.
- Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.
- Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?
- Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.
- Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
- Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.
- Cognitive response to estradiol in postmenopausal women is modified by high cortisol.
- The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ?3/?3 genotype.
- Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer''s disease: results of a randomized controlled trial.
- NSAIDs may protect against age-related brain atrophy.
- Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults.
- Awareness of memory abilities in community-dwelling older adults with suspected dementia and mild cognitive impairment.
- White matter is altered with parental family history of Alzheimer's disease.
- Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.
- Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias.
- Effects of insulin and octreotide on memory and growth hormone in Alzheimer''s disease.
- Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study".
- A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women.
- Structural MRI discriminates individuals with Mild Cognitive Impairment from age-matched controls: a combined neuropsychological and voxel based morphometry study.
- The influence of parental history of Alzheimer''s disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory.
- Effect of parental family history of Alzheimer's disease on serial position profiles.
- A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer''s disease in males carrying an apolipoprotein E epsilon4 ...
- Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review.
- Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer''s disease.
- fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer''s disease.
- Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy.
- Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults.
- Associative learning over trials activates the hippocampus in healthy elderly but not mild cognitive impairment.
- Anosognosia in mild cognitive impairment: Relationship to activation of cortical midline structures involved in self-appraisal.
- The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.
- Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer''s disease: a cross-sectional study.
- Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease.
- Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.
- Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults.
- Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
- Masculine vitality: pros and cons of testosterone in treating the andropause.
- Estrogen and cognition: a true relationship?
- Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer''s disease: interactions with apolipoprotein E genotype.
- Estrogen and cognition: the story so far.
- 17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study.
- Estrogen and Alzheimer''s disease: the story so far.
Schools
University College Of Medical Sciences Delhi University
Safdarjung Hospital
Genl Hospital
Stepping Hill Hospital
University Hospital
Johns Hopkins University
Doctors Specialties
- Geriatric Medicine
- Internal Medicine
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Johns Hopkins University -
Delhi University College of Medical Sciences
Hospital
-
William S. Middleton Memorial Veterans Hospital
Drug Facts
| NPI NUMBER | 1932176526 | |
| NPPES Provider LastName | ASTHANA | |
| NPPES Provider FirstName | SANJAY | |
| NPPES Provider ZIPCode | 53705 | |
| NPPES Provider State | WI | |
| Specialty Description | Geriatric Medicine | |
| Total Claim Count | 34.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932176526 |
| Last Name Of The Provider | ASTHANA |
| First Name Of The Provider | SANJAY |
| View All |
Similar Doctors
|
|
Dr. Cynthia M. Carlsson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Siebers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdul M. Kenj Halabi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy J. Kind, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert D. Gilbert, MD |
|
|
Dr. Jason A. Dambach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Megan Oeth, PTA |
|
|
Dr. Chad E. Schneider, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Blythe K. Belzer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald A. Daugherty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas Hartjes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea K. Schnell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffery B. Davis, DDS
This Doctor is OpenDoctor Recommended.
|